Nothing More to Be Done
Palliative Care Versus Exerimental Therapy in Advanced Cancer
Datos Bibliográficos
| ID | 4516201 |
|---|---|
| Autores | Ilana Löwy (0000-0001-6963-0578, Hôpital Necker-Enfants Malades, autor de correspondencia) |
| Año | 1995 |
| Volumen | 8 |
| Número | 1 |
| Páginas | 209-229 |
| Fecha de publicación | 1995-01-01 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | Science in Context (JOURNAL) |
| Identificadores de la revista | ISSN: 0269-8897 • E-ISSN: 1474-0664 |
| Editorial | Cambridge University Press (CUP) (PUBLISHER) |
| DOI | 10.1017/s0269889700001964 |
| PMID | 11639655 |
| OpenAlex | W2135096402 |
| Idioma | EN |
| Citas recibidas | 7 |
| Referencias citadas | 40 |
The ArgumentPatients suffering from advanced, incurable cancer often receive from their doctors proposals to enroll in a clinical trial of an experimental therapy. Experimental therapies are increasingly perceived not as a highly problematic approach but as a near-standard way to deal with incurable cancer. There are, however, important differences in the diffusion of these therapies in Western countries. The large diffusion of experimental therapies for malignant disease in the United States contrasts with the much more restricted diffusion of these therapies in the United Kingdom. The difference between the two reflects differences in the organization of health care in these countries and distinct patterns of the professionalization of medical oncology in America and in Britain. The high density and great autonomy of medical oncologists in the United States encourages there the diffusion of experimental therapies (regarded by some as expensive and inefficient); the lower density of these specialists in the United Kingdom and their task as consultants and not primary caregivers, favors the choice of more conservative (for some, too conservative) treatments. Theoretically, the decision as to whether patients suffering from advanced, incurable cancer will be steered toward an experimental therapy or toward palliative care depends on the values and beliefs of these patients and their physicians. In practice, however, such choice does not depend exclusively on the individual' cultural background and ethical values, but is also strongly affected by the - culturally conditioned - Professional and institutional structure of medicine
Autonomy · Cancer · Disease · Family medicine · Health care · Nothing · Palliative care · Political science · Professionalization · Biomedical Ethics and Regulation · Ethics in Clinical Research · Law · Medicine · Nursing · Palliative Care and End-of-Life Issues · Internal Medicine
Paradoxes of care in phase I cancer clinical trials
So Long, Succor
From Screening to Clinical Research
Les paradoxes du care dans les essais cliniques de phase I en oncologie
The Role of Algorithms in Molecular Tumour Boards-Managing the Gap Between Research and Clinic in Precision Medicine
Problems and promises of the protocol
Disclosure practices and cultural narratives
Images and Interpretations of Severe Illness: Ethnological Aspects of Dealing with Cancer
Social Science Perspectives on Medical Ethics
Culture, Cancer, and Communication in Italy
The Dread Disease
The Social construction of technological systems
Critical Theory of Technology
Strategy in American Cancer Research After World War II
Critical Theory of Technology
The Painful Prescription
The Sociology of Science
Medical Nemesis
Coping with parents
| Obras citantes distintas | 7 |
|---|---|
| Citas por año | 0,24 |
| Intervalo de citas | 1997 - 2025 (29) |
| Velocidad de citación | recent |
| Altamente citado | No |
| Tipos de cita | Neutras: 4 |